Frontiers in Cellular Neuroscience (Sep 2019)

Normal and Pathological Tau Uptake Mediated by M1/M3 Muscarinic Receptors Promotes Opposite Neuronal Changes

  • Viktoriya Morozova,
  • Viktoriya Morozova,
  • Leah S. Cohen,
  • Ali El-Hadi Makki,
  • Alison Shur,
  • Alison Shur,
  • Guillermo Pilar,
  • Abdeslem El Idrissi,
  • Abdeslem El Idrissi,
  • Alejandra D. Alonso,
  • Alejandra D. Alonso

DOI
https://doi.org/10.3389/fncel.2019.00403
Journal volume & issue
Vol. 13

Abstract

Read online

The microtubule associated protein tau is mainly found in the cell’s cytosol but recently it was also shown in the extracellular space. In neurodegenerative diseases, like Alzheimer’s disease (AD), pathological tau spreads from neuron to neuron enhancing neurodegeneration. Here, we show that HEK293 cells and neurons in culture uptake extracellular normal and pathological Tau. Muscarinic receptor antagonists atropine and pirenzepine block 80% this uptake. CHO cells do not express these receptors therefore cannot uptake tau, unless transfected with M1 and/or M3 receptor. These results strongly suggest that muscarinic receptors mediate this process. Uptake of normal tau in neurons enhances neuronal process formation but a pseudophosphorylated form of tau (pathological human tau, PH-Tau) disrupts them and accumulates in the somatodendritic compartment. AD hyperphosphorylated tau (AD P-Tau) has similar effects as PH-Tau on cultured neurons. Addition of either PH-Tau or AD P-tau to neuronal cultures induced microglial activation. In conclusion, uptake of extracellular tau is mediated by muscarinic receptors with opposite effects: normal tau stabilizes neurites; whereas pathological tau disrupts this process leading to neurodegeneration.

Keywords